Cargando…

The quest for personalized B-cell depletion therapy in rheumatic disease

Although B cell depletion therapy (BCDT) is now a well-accepted therapeutic option in autoimmune rheumatic disease, a significant proportion of patients remain resistant to therapy. .19pt?>A more challenging clinical problem is the high rate of relapse after B cell reconstitution, as well as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistala, Kiran, Mauri, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075349/
https://www.ncbi.nlm.nih.gov/pubmed/25166212
http://dx.doi.org/10.1186/ar4595

Ejemplares similares